Recognizing the difficulties that dermatology and rheumatology specialists face in collaborating on patient care in a clinical environment in which disciplinary silos are still the status quo, in this issue of Rheumatology Nurse Practice, we will review information about the prevalence of psoriatic arthritis (PsA) among patients with psoriasis, as well as tools that dermatologists can use to recognize PsA in their patients. We will also discuss various models that dermatology specialists, rheumatology specialists, and other clinicians can use to work together to improve outcomes for patients with PsA.
Carrie Beach, BSN, RN-BC
Board Certified in Rheumatology Nursing
Staff Rheumatology Nurse
Columbus Arthritis Center
Joni Fontenot, RN
Ochsner Health System-The Grove-Infusion/Rheumatology Infusion
Baton Rouge, LA
April Johnson, MSN, APRN, CNP
This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.
After participating in the activity, learners should be better able to:
● Explain the relationship between psoriasis and psoriatic arthritis (PsA)
● Discuss factors that should trigger a referral to rheumatology in patients diagnosed with
● Analyze the clinical evidence supporting the use of multidisciplinary care among patients
diagnosed with PsA
● Assess the viability of a multidisciplinary rheumatology-dermatology clinic in your practice
Accreditation and Credit Designation
The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500)
Participants will receive 2.75 hours of continuing nursing contact hours by completing the education, completing an online evaluation, and receiving a post-test score of 70%.
According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the
presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.
Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education, with the exception of the following:
Carrie Beach, RN-BC, BSN, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Janssen/A, Aurinia/SB.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information, including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please go to rnsnurse.com/rnpce and complete the post-test (achieving a passing grade of 70% or greater) and program evaluation. Your certificate will be available to you upon completion.
© 2021. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission for its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Expiration: This course will expire on November 15, 2022